Abstract
Neglected diseases are infectious diseases that affect poor people of tropical countries. Drug resistance, lower availability of funds and research hinder the opportunities for the development of new drugs. The need for new drugs will persist until pathogens are eradicated. This calls for understanding the disease prognosis to initiate research for new drug targets and thus development of new drugs. As drug development is complex and expensive process, in silico drug development can aid in this regard by reducing time, effort and capital for the quest of a “better drug” for such neglected diseases. Recent knowledge about the genome and proteome has increased enthusiasm for the quest of new drug targets. One such potential target can be lipases which are involved in the lipid metabolism of pathogens. Lipases of pathogens have multitude of functions in many patho-physiological processes including virulence, transmission, life cycle development, modulation of host lipids and host immune responses. Thus the aim of this review is to describe the significance of lipases in the life cycle and pathogenesis of the pathogen and whether they can be used as drug targets. The development of research in this direction has also been brought forward. This may help in finding new drug targets for neglected disease.
Keywords: Neglected tropical disease, drug resistance, pathogenecity, lipid metabolism, lipase, drug target.
Current Protein & Peptide Science
Title:Significance of Lipolytic Enzymes in Pathogenesis and Treatment of Neglected Diseases
Volume: 17 Issue: 3
Author(s): Debamitra Chakravorty and Sanjukta Patra
Affiliation:
Keywords: Neglected tropical disease, drug resistance, pathogenecity, lipid metabolism, lipase, drug target.
Abstract: Neglected diseases are infectious diseases that affect poor people of tropical countries. Drug resistance, lower availability of funds and research hinder the opportunities for the development of new drugs. The need for new drugs will persist until pathogens are eradicated. This calls for understanding the disease prognosis to initiate research for new drug targets and thus development of new drugs. As drug development is complex and expensive process, in silico drug development can aid in this regard by reducing time, effort and capital for the quest of a “better drug” for such neglected diseases. Recent knowledge about the genome and proteome has increased enthusiasm for the quest of new drug targets. One such potential target can be lipases which are involved in the lipid metabolism of pathogens. Lipases of pathogens have multitude of functions in many patho-physiological processes including virulence, transmission, life cycle development, modulation of host lipids and host immune responses. Thus the aim of this review is to describe the significance of lipases in the life cycle and pathogenesis of the pathogen and whether they can be used as drug targets. The development of research in this direction has also been brought forward. This may help in finding new drug targets for neglected disease.
Export Options
About this article
Cite this article as:
Chakravorty Debamitra and Patra Sanjukta, Significance of Lipolytic Enzymes in Pathogenesis and Treatment of Neglected Diseases, Current Protein & Peptide Science 2016; 17 (3) . https://dx.doi.org/10.2174/1389203717999160226173614
DOI https://dx.doi.org/10.2174/1389203717999160226173614 |
Print ISSN 1389-2037 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5550 |
Call for Papers in Thematic Issues
Advancements in Proteomic and Peptidomic Approaches in Cancer Immunotherapy: Unveiling the Immune Microenvironment
The scope of this thematic issue centers on the integration of proteomic and peptidomic technologies into the field of cancer immunotherapy, with a particular emphasis on exploring the tumor immune microenvironment. This issue aims to gather contributions that illustrate the application of these advanced methodologies in unveiling the complex interplay ...read more
Artificial Intelligence for Protein Research
Protein research, essential for understanding biological processes and creating therapeutics, faces challenges due to the intricate nature of protein structures and functions. Traditional methods are limited in exploring the vast protein sequence space efficiently. Artificial intelligence (AI) and machine learning (ML) offer promising solutions by improving predictions and speeding up ...read more
Nutrition and Metabolism in Musculoskeletal Diseases
The musculoskeletal system consists mainly of cartilage, bone, muscles, tendons, connective tissue and ligaments. Balanced metabolism is of vital importance for the homeostasis of the musculoskeletal system. A series of musculoskeletal diseases (for example, sarcopenia, osteoporosis) are resulted from the dysregulated metabolism of the musculoskeletal system. Furthermore, metabolic diseases (such ...read more
Protein Folding, Aggregation and Liquid-Liquid Phase Separation
Protein folding, misfolding and aggregation remain one of the main problems of interdisciplinary science not only because many questions are still open, but also because they are important from the point of view of practical application. Protein aggregation and formation of fibrillar structures, for example, is a hallmark of a ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Adeno-Associated Viral Vectors for Clinical Gene Transfer Studies
Current Gene Therapy The Neuroprotective Role of PEDF: Implication for the Therapy of Neurological Disorders
Current Molecular Medicine Nanomedicine in Therapeutic Intervention of Tuberculosis Meningitis
Current Nanoscience Sedation in PACU: The Role of Propofol
Current Drug Targets Cholesterol, Alzheimers Disease, Prion Disorders: A menage a trois?
Current Drug Targets The Valsalva Maneuver and Alzheimers Disease: Is there a link?
Current Alzheimer Research Notch Signaling in Cardiovascular Disease and Calcification
Current Cardiology Reviews Tissue Protective and Anti-Fibrotic Actions of Suramin: New Uses of an Old Drug
Current Clinical Pharmacology Targeting the Formation of the Cell Wall Core of M. tuberculosis
Infectious Disorders - Drug Targets CD14-Dependent Innate Immunity-Mediated Neuronal Damage in Vivo is Suppressed by NSAIDs and Ablation of a Prostaglandin E2 Receptor, EP2
Current Medicinal Chemistry - Central Nervous System Agents Mitochondrial Alterations and Neuropsychiatric Disorders
Current Medicinal Chemistry Abeta DNA Vaccination for Alzheimers Disease: Focus on Disease Prevention
CNS & Neurological Disorders - Drug Targets Targeting Negative Regulators of TRIF-dependent TLR Signaling Pathway as a Novel Therapeutic Strategy
Current Signal Transduction Therapy Outcome of Newborns with Neonatal Seizures: Risk Factors and Predictors
Current Pediatric Reviews TRPV1 Antagonists as a Potential Treatment for Hyperalgesia
Recent Patents on CNS Drug Discovery (Discontinued) Biological Properties of Plant-Derived Alkylresorcinols: Mini-Review
Mini-Reviews in Medicinal Chemistry Mitophagy and Disease: New Avenues for Pharmacological Intervention
Current Pharmaceutical Design Platelet Activating Factor/Platelet Activating Factor Receptor Pathway as a Potential Therapeutic Target in Autoimmune Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Understanding the Role of Hypoxia Inducible Factor During Neurodegeneration for New Therapeutics Opportunities
Current Neuropharmacology Development and Characterization of Linezolid loaded Biocompatible Solidlipid based Nanocarrier for Enhanced Lung Deposition and Anti-tubercular Activity: Next Generation tailor-made Carrier for Dry Powder Inhaler
Current Indian Science